Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocamus and nucleus accumbens of rats

被引:23
作者
Sharp, BM [1 ]
Yatsula, M [1 ]
Fu, YT [1 ]
机构
[1] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Memphis, TN 38163 USA
关键词
D O I
10.1124/jpet.103.063586
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Galantamine, a drug for treatment of Alzheimer's disease, is a novel cholinergic agent with a dual mode of action that inhibits acetylcholinesterase and allosterically modulates nicotinic cholinergic receptors (nAChRs). Nicotine stimulates catecholamine secretion, inducing hippocampal norepinephrine (NE) release, and improves memory consolidation. Thus, the effect of galantamine on nicotine-induced hippocampal NE secretion was investigated. This was compared with the effect of galantamine on nicotine-induced dopamine (DA) release within the nucleus accumbens of the same rat. Nicotine (0.025-0.09 mg/kg i.v.) dose dependently increased NE and DA levels in microdialysates from the hippocampus and nucleus accumbens, respectively, of freely moving rats. Pretreatment with galantamine (3.0 mg/kg s.c.) 3 h before nicotine either potentiated NE responses to doses of nicotine that were ineffective alone (0.025-0.045 mg/kg) or significantly enhanced (0.065 mg/kg) NE responses, whereas galantamine was ineffective when administered 2 or 4 h before nicotine. In contrast to its effects on NE, galantamine did not alter accumbal DA responses to any dose of nicotine. These selective effects of galantamine on nicotine-stimulated NE secretion may reflect differences in local neural circuits that use nAChRs to modulate hippocampal NE versus accumbal DA release.
引用
收藏
页码:1116 / 1123
页数:8
相关论文
共 42 条
[1]   IMPAIRED LEARNING AND DECREASED CORTICAL NOREPINEPHRINE AFTER BILATERAL LOCUS COERULEUS LESIONS [J].
ANLEZARK, GM ;
CROW, TJ ;
GREENWAY, AP .
SCIENCE, 1973, 181 (4100) :682-684
[2]  
Aston-Jones Gary, 1995, P183
[3]   Chronic treatment of old rats with donepezil or galantamine: Effects on memory, hippocampal plasticity and nicotinic receptors [J].
Barnes, CA ;
Meltzer, J ;
Houston, F ;
Orr, G ;
McGann, K ;
Wenk, GL .
NEUROSCIENCE, 2000, 99 (01) :17-23
[4]   Drugs acting upon the cyclic adenosine monophosphate protein kinase A signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala [J].
Bevilaqua, L ;
Ardenghi, P ;
Schroder, N ;
Bromberg, E ;
Schmitz, PK ;
Schaeffer, E ;
Quevedo, J ;
Bianchin, M ;
Walz, R ;
Medina, JH ;
Izquierdo, I .
BEHAVIOURAL PHARMACOLOGY, 1997, 8 (04) :331-338
[5]   LOSS OF NEURONS OF ORIGIN OF THE ADRENERGIC PROJECTION TO CEREBRAL-CORTEX (NUCLEUS LOCUS CERULEUS) IN SENILE DEMENTIA [J].
BONDAREFF, W ;
MOUNTJOY, CQ ;
ROTH, M .
NEUROLOGY, 1982, 32 (02) :164-168
[6]   alpha(2)-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat [J].
Camacho, F ;
Smith, CP ;
Vargas, HM ;
Winslow, JT .
PSYCHOPHARMACOLOGY, 1996, 124 (04) :347-354
[7]   EFFECTS OF LESIONS TO ASCENDING NORADRENERGIC NEURONS ON PERFORMANCE OF A 5-CHOICE SERIAL REACTION TASK IN RATS - IMPLICATIONS FOR THEORIES OF DORSAL NORADRENERGIC BUNDLE FUNCTION BASED ON SELECTIVE ATTENTION AND AROUSAL [J].
CARLI, M ;
ROBBINS, TW ;
EVENDEN, JL ;
EVERITT, BJ .
BEHAVIOURAL BRAIN RESEARCH, 1983, 9 (03) :361-380
[8]  
Corey-Bloom J, 2003, INT J CLIN PRACT, V57, P219
[9]   CONCURRENT MUSCARINIC AND BETA-ADRENERGIC-BLOCKADE IN RATS IMPAIRS PLACE-LEARNING IN A WATER MAZE AND RETENTION OF INHIBITORY AVOIDANCE [J].
DECKER, MW ;
GILL, TM ;
MCGAUGH, JL .
BRAIN RESEARCH, 1990, 513 (01) :81-85
[10]   Role of dopamine in the behavioural actions of nicotine related to addiction [J].
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :295-314